In 2018, the APC agreed to adopt the Sheffield Denosumab 60mg/mL Injection (Prolia®) prescribing guidelines:
THE SHEFFIELD AREA PRESCRIBING COMMITTEE (sheffieldccg.nhs.uk)
In November 2022 guidance was developed on Denosumab (Prolia®) for Primary Care Clinicians; where patients have been previously initiated on Denosumab (Prolia®) as Shared Care by Barnsley Osteoporosis Service (patients are no longer under hospital supervision).
Date: 01 September 2022 to 31 December 2098
Do you want to add this to your CPD record?
Did you find this page helpful?
© 2024
Website by Sitekit, body system icons designed by Freepik